The Effect of Intravenous Procainamide on the HV Interval at Electrophysiologic Study

Steven E. Girard, Thomas M. Munger, Stephen C. Hammill, Win Kuang Shen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The His bundle electrogram recorded at electrophysiologic study clearly differentiates atrioventricular (AV) node disease from distal conduction system disease. The distal conduction system may be tested further by infusing procainamide (10-15 mg/kg) intravenously. High-grade distal AV block or prolongation of the HV interval >80 ms was defined as an abnormal response to this test. We retrospectively reviewed the medical records of 79 patients who underwent electrophysiologic study with intravenous procainamide. An abnormal response to procainamide was observed in only 3% of 37 patients with a normal baseline HV (≤55 ms), in 48% of 27 patients with mild HV prolongation (56 to 70 ms), and in all 15 patients with moderate HV prolongation (>70 ms) (P <0.0001 for the trend). Procainamide induced high-grade AV block in 4 of 28 patients (14%) studied for syncope and in 1 of 51 patients (2%) studied for ventricular tachycardia. Syncope as the indication for electrophysiologic study (P = 0.05) and left bundle branch block morphology (P = 0.03) were predictors of high-grade AV block; baseline HV and QTc intervals were significantly prolonged in patients who developed AV block with procainamide. We identified a strong linear correlation (R = 0.85) between post-drug and baseline HV intervals, with a regression slope of 1.17 ± 0.09 and an intercept (± standard error) of 5.8 ± 5.0 ms. This linear response to procainamide and published prospective studies support pacing syncope patients with baseline HV >70 ms. Therefore, procainamide infusion during the electrophysiologic study of patients with undifferentiated syncope should be reserved for those with mild HV prolongation from approximately 55 to 70 ms.

Original languageEnglish (US)
Pages (from-to)129-137
Number of pages9
JournalJournal of Interventional Cardiac Electrophysiology
Volume3
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Procainamide
Cardiac Electrophysiologic Techniques
Atrioventricular Node
Atrioventricular Block
Syncope
Medical Records

Keywords

  • Conduction system disease
  • Heart block
  • His-Purkinje system
  • Permanent pacemaker
  • Syncope

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The Effect of Intravenous Procainamide on the HV Interval at Electrophysiologic Study. / Girard, Steven E.; Munger, Thomas M.; Hammill, Stephen C.; Shen, Win Kuang.

In: Journal of Interventional Cardiac Electrophysiology, Vol. 3, No. 2, 1999, p. 129-137.

Research output: Contribution to journalArticle

Girard, Steven E. ; Munger, Thomas M. ; Hammill, Stephen C. ; Shen, Win Kuang. / The Effect of Intravenous Procainamide on the HV Interval at Electrophysiologic Study. In: Journal of Interventional Cardiac Electrophysiology. 1999 ; Vol. 3, No. 2. pp. 129-137.
@article{80dce6e9a6f3450b8b1a7494e8ce787e,
title = "The Effect of Intravenous Procainamide on the HV Interval at Electrophysiologic Study",
abstract = "The His bundle electrogram recorded at electrophysiologic study clearly differentiates atrioventricular (AV) node disease from distal conduction system disease. The distal conduction system may be tested further by infusing procainamide (10-15 mg/kg) intravenously. High-grade distal AV block or prolongation of the HV interval >80 ms was defined as an abnormal response to this test. We retrospectively reviewed the medical records of 79 patients who underwent electrophysiologic study with intravenous procainamide. An abnormal response to procainamide was observed in only 3{\%} of 37 patients with a normal baseline HV (≤55 ms), in 48{\%} of 27 patients with mild HV prolongation (56 to 70 ms), and in all 15 patients with moderate HV prolongation (>70 ms) (P <0.0001 for the trend). Procainamide induced high-grade AV block in 4 of 28 patients (14{\%}) studied for syncope and in 1 of 51 patients (2{\%}) studied for ventricular tachycardia. Syncope as the indication for electrophysiologic study (P = 0.05) and left bundle branch block morphology (P = 0.03) were predictors of high-grade AV block; baseline HV and QTc intervals were significantly prolonged in patients who developed AV block with procainamide. We identified a strong linear correlation (R = 0.85) between post-drug and baseline HV intervals, with a regression slope of 1.17 ± 0.09 and an intercept (± standard error) of 5.8 ± 5.0 ms. This linear response to procainamide and published prospective studies support pacing syncope patients with baseline HV >70 ms. Therefore, procainamide infusion during the electrophysiologic study of patients with undifferentiated syncope should be reserved for those with mild HV prolongation from approximately 55 to 70 ms.",
keywords = "Conduction system disease, Heart block, His-Purkinje system, Permanent pacemaker, Syncope",
author = "Girard, {Steven E.} and Munger, {Thomas M.} and Hammill, {Stephen C.} and Shen, {Win Kuang}",
year = "1999",
doi = "10.1023/A:1009809212028",
language = "English (US)",
volume = "3",
pages = "129--137",
journal = "Journal of Interventional Cardiac Electrophysiology",
issn = "1383-875X",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - The Effect of Intravenous Procainamide on the HV Interval at Electrophysiologic Study

AU - Girard, Steven E.

AU - Munger, Thomas M.

AU - Hammill, Stephen C.

AU - Shen, Win Kuang

PY - 1999

Y1 - 1999

N2 - The His bundle electrogram recorded at electrophysiologic study clearly differentiates atrioventricular (AV) node disease from distal conduction system disease. The distal conduction system may be tested further by infusing procainamide (10-15 mg/kg) intravenously. High-grade distal AV block or prolongation of the HV interval >80 ms was defined as an abnormal response to this test. We retrospectively reviewed the medical records of 79 patients who underwent electrophysiologic study with intravenous procainamide. An abnormal response to procainamide was observed in only 3% of 37 patients with a normal baseline HV (≤55 ms), in 48% of 27 patients with mild HV prolongation (56 to 70 ms), and in all 15 patients with moderate HV prolongation (>70 ms) (P <0.0001 for the trend). Procainamide induced high-grade AV block in 4 of 28 patients (14%) studied for syncope and in 1 of 51 patients (2%) studied for ventricular tachycardia. Syncope as the indication for electrophysiologic study (P = 0.05) and left bundle branch block morphology (P = 0.03) were predictors of high-grade AV block; baseline HV and QTc intervals were significantly prolonged in patients who developed AV block with procainamide. We identified a strong linear correlation (R = 0.85) between post-drug and baseline HV intervals, with a regression slope of 1.17 ± 0.09 and an intercept (± standard error) of 5.8 ± 5.0 ms. This linear response to procainamide and published prospective studies support pacing syncope patients with baseline HV >70 ms. Therefore, procainamide infusion during the electrophysiologic study of patients with undifferentiated syncope should be reserved for those with mild HV prolongation from approximately 55 to 70 ms.

AB - The His bundle electrogram recorded at electrophysiologic study clearly differentiates atrioventricular (AV) node disease from distal conduction system disease. The distal conduction system may be tested further by infusing procainamide (10-15 mg/kg) intravenously. High-grade distal AV block or prolongation of the HV interval >80 ms was defined as an abnormal response to this test. We retrospectively reviewed the medical records of 79 patients who underwent electrophysiologic study with intravenous procainamide. An abnormal response to procainamide was observed in only 3% of 37 patients with a normal baseline HV (≤55 ms), in 48% of 27 patients with mild HV prolongation (56 to 70 ms), and in all 15 patients with moderate HV prolongation (>70 ms) (P <0.0001 for the trend). Procainamide induced high-grade AV block in 4 of 28 patients (14%) studied for syncope and in 1 of 51 patients (2%) studied for ventricular tachycardia. Syncope as the indication for electrophysiologic study (P = 0.05) and left bundle branch block morphology (P = 0.03) were predictors of high-grade AV block; baseline HV and QTc intervals were significantly prolonged in patients who developed AV block with procainamide. We identified a strong linear correlation (R = 0.85) between post-drug and baseline HV intervals, with a regression slope of 1.17 ± 0.09 and an intercept (± standard error) of 5.8 ± 5.0 ms. This linear response to procainamide and published prospective studies support pacing syncope patients with baseline HV >70 ms. Therefore, procainamide infusion during the electrophysiologic study of patients with undifferentiated syncope should be reserved for those with mild HV prolongation from approximately 55 to 70 ms.

KW - Conduction system disease

KW - Heart block

KW - His-Purkinje system

KW - Permanent pacemaker

KW - Syncope

UR - http://www.scopus.com/inward/record.url?scp=0033162596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033162596&partnerID=8YFLogxK

U2 - 10.1023/A:1009809212028

DO - 10.1023/A:1009809212028

M3 - Article

VL - 3

SP - 129

EP - 137

JO - Journal of Interventional Cardiac Electrophysiology

JF - Journal of Interventional Cardiac Electrophysiology

SN - 1383-875X

IS - 2

ER -